1. Home
  2. FTCI vs VRCA Comparison

FTCI vs VRCA Comparison

Compare FTCI & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$4.37

Market Cap

122.4M

Sector

Technology

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.81

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
VRCA
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.4M
137.3M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
FTCI
VRCA
Price
$4.37
$5.81
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$10.80
$17.00
AVG Volume (30 Days)
193.1K
85.5K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$99,687,000.00
$35,577,000.00
Revenue This Year
$65.44
N/A
Revenue Next Year
$45.97
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
110.51
370.22
52 Week Low
$3.21
$0.49
52 Week High
$12.75
$9.82

Technical Indicators

Market Signals
Indicator
FTCI
VRCA
Relative Strength Index (RSI) 45.98 39.60
Support Level $3.30 $5.13
Resistance Level $5.31 $6.40
Average True Range (ATR) 0.54 0.68
MACD 0.01 -0.22
Stochastic Oscillator 50.36 4.42

Price Performance

Historical Comparison
FTCI
VRCA

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: